Figure 1
HLA A-B-C antigen expression during in vitro differentiation with ATRA 10 −7 m. APL cells isolated from patients harboring either bcr1 or bcr3 PMLRAR␣ subtype were cultured 6 days in the absence (grey bars) or in the presence of ATRA 10 −7 m (white bars). Each bar represents the mean ± s.d. of HLA A-B-C expression for all patients (n = 10).
First non-imported HTLV-1 positive adult T cell leukemia/lymphoma (ATLL) in Germany

TO THE EDITOR
We report the first non-imported HTLV-1 positive adult T cell leukemia/lymphoma in Germany. A 41-year-old German mother of a healthy 12-year-old girl was admitted for generalized lymphadenopathy, splenomegaly, a macular exanthema and fever, all having developed within the past 2 weeks. The patient was confused and somnolent. No other abnormalities were observed at physical examination. Radiological assessment revealed a bilateral mediastinal lymph node enlargement. A magnetic resonance imaging (MRI) of the skull disclosed no abnormalities. Laboratory analyses displayed a normal hemoglobin and thrombocyte count, leukocytes were 45 G/l with 36% atypical flower-like lymphoid cells, creatinine was 2.04 (normal range: 0.3-1.0) mg/dl and calcium was 4.43 (2.10-2.60) mmol/l, lactate dehydrogenase was also elevated with 800 (230-400) U/l. Immunophenotyping of peripheral blood mononuclear cells identified the atypical cells as CD3
− mature T cells. Histologic examination of a lymph node biopsy showed an architecture destroyed by a CD3 + and BCL-2
− and CD15 − peripheral T cell lymphoma with a growth rate of 40%. The bone marrow biopsy disclosed an extended infiltration by the malignant T cell population. Pleocytosis and blasts were also seen in the cerebrospinal fluid (CSF). Antibodies against HTLV-1/2 were found in CSF and serum. A Western blot identified the characteristic anti-HTLV-1 band pattern both in patient's serum and CSF. Type-specific PCR analysis targeted to fragments of pol identified HTLV-1 as the integrated virion. High serum levels of soluble interleukin-2 receptor (s-IL-2R) as well as soluble tumor necrosis factor receptor type II (s-TNF R II) were recorded (Immulite, DPC Biermann, Germany). The patient had no history of i.v. drug abuse, blood transfusion or contact to residents of HTLV-1 endemic areas. The serology for HIV-1/2 and HBV was negative, while IgG antibodies were detected against VZV, CMV and EBV. Cytogenetic studies of peripheral blood lymphocytes (PBL) revealed consistent structural aberrations. The aberrant karyotype was: 46,X?ins(X;9)(q27;q21q33), +der(7;18)(q10;q10),-14, der(14) t(14;14)(q11;q32.1). After PstI/XhoI digestion of genomic DNA purified from pre-therapy PBL, Southern blot analysis indicated a 9 kb DNA fragment ( Figure 1, lane 3) suggesting clonal integration of the HTLV-1 provirus. After diagnosis of an acute ATLL and correction of the electrolyte imbalance, a chemotherapy according to the CHOP protocol (cyclophosphamide 1200 mg day 1, doxorubicin 80 mg day 1, vincristine 2 mg day 1, prednisone 180 mg days 1-5) in 3-week intervals as well as intrathecal (i.th.) instillations of methotrexate (MTX) 15 mg, cytarabin Ara-C 40 mg and dexamethasone 4 mg on days 1 and 8 of CHOP was initiated. A rapid improvement of the clinical status and laboratory parameters was achieved (Figure 2 ). Complete remission was documented after three courses of CHOP and six i.th. instillations. After a total of four courses of CHOP and eight i.th instillations a maintenance therapy with zidovudine 4 × 250 mg and interferon-␣ (IFN-␣) 5 × 10 6 U s.c. 1 was begun. Two months later the patient was readmitted with seizures and a peripheral dysesthesia. A MRI disclosed lesions in the right orbita and optical nerve, CSF microscopy showed leukemic meningiosis, thus a radiotherapy of the right orbita, skull and neuroaxis with a total of 28 Gy was initiated. The treatment was complicated by a bilateral invasive pulmonary aspergillosis treated with amphotericin B. No further antileukemic therapy was implemented and the patient was treated symptomatically. The patient died of fungal septicemia 10 months after initial diagnosis.
The rapid disease progression and short survival are typical of the acute form of ATLL. Furthermore, the translocation t(14;14) (q11;q32.1) is a typical chromosome aberration of ATLL resulting in an upregulation of the TCL-1 gene by juxtaposition next to the PCR-␣/␦-locus; while trisomy 7q due to a whole arm translocation between 7q and 18q is associated with the acute form of ATLL. 3 Although a complete remission was achieved with systemic and intrathecal chemotherapy, a maintenance therapy with zidovudine/ IFN-␣ did not prevent an early CNS relapse. Therefore, similar to the treatment of acute lymphoblastic leukemias, prolonged cytostatic treatment and early CNS radiotherapy might be beneficial in the treatment of ATLL with initial CNS involvement.
The disease activity and high tumor load was reflected by the serum levels of LDH, s-IL-2R 4 and s-TNF R (Figure 2) . However, increasing With a low-risk history and negative serology for HIV-1/2 and HBV, an HTLV-1 infection caused by poor medical standards, sexual transmission, needle sharing or needle stick appears unlikely. While the patient's healthy husband was not willing to undergo serologic testing, the patient's 12-year-old daughter was seronegative and PCR-negative for HTLV-1/2. This, however, does not necessarily imply a post-delivery infection of the patient, but suggests a low level of viremia at the time.
